Literature DB >> 34668298

Improving prediction of anticoagulant-related major bleeding in atrial fibrillation: The search for new biomarkers.

David D Berg1, David A Morrow1.   

Abstract

Entities:  

Keywords:  atrial fibrillation; biomarkers; bleeding; proteomics; risk prediction

Mesh：

Substances：

Year:  2021        PMID： 34668298      PMCID： PMC8864724          DOI： 10.1111/jth.15525

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN： 1538-7836            Impact factor:   5.824


× No keyword cloud information.
  16 in total

1.  Rivaroxaban versus warfarin in nonvalvular atrial fibrillation.

Authors:  Manesh R Patel; Kenneth W Mahaffey; Jyotsna Garg; Guohua Pan; Daniel E Singer; Werner Hacke; Günter Breithardt; Jonathan L Halperin; Graeme J Hankey; Jonathan P Piccini; Richard C Becker; Christopher C Nessel; John F Paolini; Scott D Berkowitz; Keith A A Fox; Robert M Califf
Journal:  N Engl J Med       Date:  2011-08-10       Impact factor: 91.245

2.  Benchmarks for the assessment of novel cardiovascular biomarkers.

Authors:  David A Morrow; James A de Lemos
Journal:  Circulation       Date:  2007-02-27       Impact factor: 29.690

3.  The novel biomarker-based ABC (age, biomarkers, clinical history)-bleeding risk score for patients with atrial fibrillation: a derivation and validation study.

Authors:  Ziad Hijazi; Jonas Oldgren; Johan Lindbäck; John H Alexander; Stuart J Connolly; John W Eikelboom; Michael D Ezekowitz; Claes Held; Elaine M Hylek; Renato D Lopes; Agneta Siegbahn; Salim Yusuf; Christopher B Granger; Lars Wallentin
Journal:  Lancet       Date:  2016-04-04       Impact factor: 79.321

4.  Performance of the ABC Scores for Assessing the Risk of Stroke or Systemic Embolism and Bleeding in Patients With Atrial Fibrillation in ENGAGE AF-TIMI 48.

Authors:  David D Berg; Christian T Ruff; Petr Jarolim; Robert P Giugliano; Francesco Nordio; Hans J Lanz; Michele F Mercuri; Elliott M Antman; Eugene Braunwald; David A Morrow
Journal:  Circulation       Date:  2019-02-05       Impact factor: 29.690

Review 5.  Biomarkers for Risk Assessment in Atrial Fibrillation.

Authors:  David D Berg; Christian T Ruff; David A Morrow
Journal:  Clin Chem       Date:  2021-01-08       Impact factor: 8.327

6.  Multiplex protein screening of biomarkers associated with major bleeding in patients with atrial fibrillation treated with oral anticoagulation.

Authors:  Agneta Siegbahn; Johan Lindbäck; Ziad Hijazi; Mikael Åberg; John H Alexander; John W Eikelboom; Renato D Lopes; Tymon Pol; Jonas Oldgren; Christopher B Granger; Salim Yusuf; Lars Wallentin
Journal:  J Thromb Haemost       Date:  2021-08-24       Impact factor: 5.824

7.  Major bleeding in patients with atrial fibrillation receiving apixaban or warfarin: The ARISTOTLE Trial (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation): Predictors, Characteristics, and Clinical Outcomes.

Authors:  Elaine M Hylek; Claes Held; John H Alexander; Renato D Lopes; Raffaele De Caterina; Daniel M Wojdyla; Kurt Huber; Petr Jansky; Philippe Gabriel Steg; Michael Hanna; Laine Thomas; Lars Wallentin; Christopher B Granger
Journal:  J Am Coll Cardiol       Date:  2014-03-19       Impact factor: 24.094

8.  Biomarker-Based Risk Prediction With the ABC-AF Scores in Patients With Atrial Fibrillation Not Receiving Oral Anticoagulation.

Authors:  Alexander P Benz; Ziad Hijazi; Johan Lindbäck; Stuart J Connolly; John W Eikelboom; Jonas Oldgren; Agneta Siegbahn; Lars Wallentin
Journal:  Circulation       Date:  2021-04-14       Impact factor: 29.690

9.  Screening of Multiple Biomarkers Associated With Ischemic Stroke in Atrial Fibrillation.

Authors:  Ziad Hijazi; Lars Wallentin; Johan Lindbäck; John H Alexander; Stuart J Connolly; John W Eikelboom; Michael D Ezekowitz; Christopher B Granger; Renato D Lopes; Tymon Pol; Salim Yusuf; Jonas Oldgren; Agneta Siegbahn
Journal:  J Am Heart Assoc       Date:  2020-12-09       Impact factor: 5.501

10.  A Targeted Proteomic Approach Identifies Novel Biomarkers of Arterial Thromboembolic Risk in ENGAGE AF-TIMI 48.

Authors:  David D Berg; Robert P Giugliano; Christian T Ruff; Minao Tang; KyungAh Im; Petr Jarolim; Howard Rutman; Elliott M Antman; Eugene Braunwald; David A Morrow
Journal:  J Am Coll Cardiol       Date:  2021-08-10       Impact factor: 24.094
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.